Navigation Links
Dr. David Ellis and the Art of Facial Surgery Announces the Availability of Juvederm® Volift® With Lidocaine
Date:8/25/2014

Toronto, ON (PRWEB) August 25, 2014

Dr. David Ellis of the Art of Facial Surgery is among the first doctors in the Toronto Area to offer Juvederm® Volift® with Lidocaine. This is the latest addition to the family of Juvederm® products of dermal fillers promising to lift, revitalize and define the face’s natural contours. Dr. Ellis is pleased to bring Juvederm®Volift® to Toronto and allow clients to experience the difference that European patients are already enjoying.

Juvederm® Volift® is already receiving accolades in Europe, for the ability to smooth deep wrinkles as it refreshes and restores the face’s natural contours. Juvederm® Volift® is the perfect partner for Dr. Ellis and the Art of Facial Surgery whose team works to deliver, in a warm and caring environment, the best outcome for patients with the latest state of the art technology.

Juvederm® Volift® is a hyaluronic acid, a protein that occurs naturally in the body. The addition of Lidocaine, a local anesthetic, makes the treatment very comfortable for the patient. Designed specifically for facial contouring; it is particularly effective on nasolabial folds, also known as smile lines. Juvederm® Volift® offers results lasting up to fifteen months.

“New Juvederm® Volift® with lidocaine uses the new VYCROSS™ technology to give an ultra-smooth, natural look and feel with minimal swelling and bruising.” says Dr. David Ellis.

Dr. Ellis and his team of professionals at the Art of Facial Surgery in Toronto are ready to provide patients with the results to look and feel the absolute best. For more information on Juvederm® Volift® with Lidocaine call on Dr. Ellis at the Art of Facial Surgery at 1.416.229.1050 or via the web at info@artoffacialsurgery.com. The knowledgeable and friendly staff will answer questions and concerns and set up an appointment with Dr. Ellis to determine if Juvederm® Volift® with Lidocaine is the appropriate choice for a refreshed, revitalized look.

About Dr. David A.F. Ellis and the Art of Facial Surgery

The Art of Facial Surgery Facial offers Cosmetic Facial Surgery Procedures including but not limited to Facelift, Rhinoplasty (nose), Blepharoplasty (lids), and implants. Alongside these surgical procedures are Aesthetic Procedures which include Botox, Microdermabrasion, skin care and products, and the latest Juvederm® Volift®, as well as Laser Procedures that include vein removal, laser hair removal, skin tightening and more. The practice is totally devoted to helping each and every patient look and feel the best!

Dr. Ellis is the founder of the Art of Facial Surgery, a professor at the University of Otolaryngology Department and teaches Facial Plastic Surgery at Toronto General Hospital’s University Health Network. Dr. Ellis specializes in facial plastic surgery and limits his practice to Plastic, Cosmetic, and Reconstructive Surgery of the face, head, and neck.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12113866.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
2. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
3. Public health expert David Dausey calls BPA ban hollow victory
4. ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton Medal
5. Childrens Nationals David Wessel receives AHA Meritorious Achievement Award
6. Center For Sight Expands Services in University Park; David Hunt, O.D., Becomes Part of Center For Sight’s Comprehensive Eye Care Team
7. Beverly Hills Dentist Dr. David Frey raises money for the Jerusalem Dental Center for Children
8. Atlanta Plastic Surgeon Dr. David Whiteman Says Increased Popularity of Ethnic Rhinoplasty, Indicated by Latest ASPS Statistics, Emphasizes Need for Experienced Surgeons
9. Dan Doctoroff, David Rubenstein, and Bloomberg Philanthropies unveil Target ALS
10. Dr. Farshchian to Interview Dr. David Santog on " The Arthritis Show"
11. Recipients of 2013 Dan David Prize announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... physical therapy provider for Derby City CrossFit, effective immediately. , In addition to ... and effectively as possible, ProRehab’s sports physical therapists will work with athletes to ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are ... help with process innovation in drug formulation and manufacturing. CoreRx offers its ... analytical equipment in support of their development and manufacturing goals. , The ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing ... acute or chronic problems, I focus on preventative care with all my patients to alleviate ... any questions, always feel free to contact my office and my trained staff will assist ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology: